Essec\Faculty\Model\Contribution {#2233 ▼
#_index: "academ_contributions"
#_id: "15456"
#_source: array:26 [
"id" => "15456"
"slug" => "15456-do-continuous-glucose-monitoring-cgm-metrics-predict-macrovascular-and-microvascular-complications-in-diabetes-the-faculty-protocol-of-a-retrospective-real-world-cohort-study 
15456-do-continuous-glucose-monitoring-cgm-metrics-predict-macrovascular-and-microvascular-complicat "
"yearMonth" => "2025-01"
"year" => "2025"
"title" => "Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications "
"description" => "AJJAN, R.A., BATTELINO, T., SEUFERT, J., BLIN, P., DE POUVOURVILLE, G., VICAUT, E. ... JOUBERT, M. (2025). Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study. <i>BMJ Open</i>, 15(1), pp. e085961. AJJAN, R.A., BATTELINO, T., SEUFERT, J., BLIN, P., DE POUVOURVILLE, G., VICAUT, E. ... JOUBERT, M. ( "
"authors" => array:10 [
0 => array:3 [
"name" => "DE POUVOURVILLE Gérard"
"bid" => "B00072308"
"slug" => "de-pouvourville-gerard"
]
1 => array:1 [
"name" => "Ajjan Ramzi A"
]
2 => array:1 [
"name" => "Battelino Tadej"
]
3 => array:1 [
"name" => "Seufert J"
]
4 => array:1 [
"name" => "Blin Patrick"
]
5 => array:1 [
"name" => "Vicaut Eric"
]
6 => array:1 [
"name" => "Carcaillon-Bentata Laure"
]
7 => array:1 [
"name" => "Levrat-Guillen Fleur"
]
8 => array:1 [
"name" => "Cosson Emmanuel"
]
9 => array:1 [
"name" => "Joubert Michael"
]
]
"ouvrage" => ""
"keywords" => array:6 [
0 => "Coronary heart disease"
1 => "Diabetes & Endocrinology"
2 => "Diabetic nephropathy & vascular disease"
3 => "Diabetic neuropathy"
4 => "Diabetic retinopathy"
5 => "Health Economics"
]
"updatedAt" => "2025-03-06 11:17:09"
"publicationUrl" => "https://doi.org/10.1136/bmjopen-2024-085961"
"publicationInfo" => array:3 [
"pages" => "e085961"
"volume" => "15"
"number" => "1"
]
"type" => array:2 [
"fr" => "Articles"
"en" => "Journal articles"
]
"support_type" => array:2 [
"fr" => "Revue scientifique"
"en" => "Scientific journal"
]
"countries" => array:2 [
"fr" => null
"en" => null
]
"abstract" => array:2 [
"fr" => "Glycated haemoglobin (HbA1c) is currently the gold standard for assessing glycaemic control in diabetes, given the established relationship with microvascular and macrovascular complications in this condition. However, HbA1c is affected by non-glycaemic factors, while also failing to provide data on hypoglycaemic exposure and glucose variability, which are associated with adverse vascular outcomes. Continuous glucose monitoring (CGM)-derived glucose metrics provide a more comprehensive assessment of glycaemia, but their role in predicting future vascular complications remains unclear. Here, we present the protocol for a real-world cohort study, aiming to establish the relationship between CGM-derived glycaemic metrics and the incidence of macrovascular and/or microvascular complications in people with diabetes. Glycated haemoglobin (HbA1c) is currently the gold standard for assessing glycaemic control in diabe "
"en" => "Glycated haemoglobin (HbA1c) is currently the gold standard for assessing glycaemic control in diabetes, given the established relationship with microvascular and macrovascular complications in this condition. However, HbA1c is affected by non-glycaemic factors, while also failing to provide data on hypoglycaemic exposure and glucose variability, which are associated with adverse vascular outcomes. Continuous glucose monitoring (CGM)-derived glucose metrics provide a more comprehensive assessment of glycaemia, but their role in predicting future vascular complications remains unclear. Here, we present the protocol for a real-world cohort study, aiming to establish the relationship between CGM-derived glycaemic metrics and the incidence of macrovascular and/or microvascular complications in people with diabetes. Glycated haemoglobin (HbA1c) is currently the gold standard for assessing glycaemic control in diabe "
]
"authors_fields" => array:2 [
"fr" => "Management"
"en" => "Management"
]
"indexedAt" => "2025-04-06T10:21:41.000Z"
"docTitle" => "Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications "
"docSurtitle" => "Articles"
"authorNames" => "<a href="/cv/de-pouvourville-gerard">DE POUVOURVILLE Gérard</a>, Ajjan Ramzi A, Battelino Tadej, Seufert J, Blin Patrick, Vicaut Eric, Carcaillon-Bentata Laure, Levrat-Guillen Fleur, Cosson Emmanuel, Joubert Michael <a href="/cv/de-pouvourville-gerard">DE POUVOURVILLE Gérard</a>, Ajjan Ramzi A, Battelino Tadej, Seu "
"docDescription" => "<span class="document-property-authors">DE POUVOURVILLE Gérard, Ajjan Ramzi A, Battelino Tadej, Seufert J, Blin Patrick, Vicaut Eric, Carcaillon-Bentata Laure, Levrat-Guillen Fleur, Cosson Emmanuel, Joubert Michael</span><br><span class="document-property-authors_fields">Management</span> | <span class="document-property-year">2025</span> <span class="document-property-authors">DE POUVOURVILLE Gérard, Ajjan Ramzi A, Battelino Tadej, Seuf "
"keywordList" => "<a href="#">Coronary heart disease</a>, <a href="#">Diabetes & Endocrinology</a>, <a href="#">Diabetic nephropathy & vascular disease</a>, <a href="#">Diabetic neuropathy</a>, <a href="#">Diabetic retinopathy</a>, <a href="#">Health Economics</a> <a href="#">Coronary heart disease</a>, <a href="#">Diabetes & Endocrinology</a>, <a href="#">Diabet "
"docPreview" => "<b>Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study</b><br><span>2025-01 | Articles </span> <b>Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complicati "
"docType" => "research"
"publicationLink" => "<a href="https://doi.org/10.1136/bmjopen-2024-085961" target="_blank">Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study</a> <a href="https://doi.org/10.1136/bmjopen-2024-085961" target="_blank">Do continuous glucose monitori "
]
+lang: "fr"
+"_type": "_doc"
+"_score": 8.550783
+"parent": null
}
